Population-based identity-by-descent mapping combined with exome sequencing to detect rare risk variants for schizophrenia

Research output: Contribution to journalJournal articlepeer-review

  • Denise Harold
  • Siobhan Connolly
  • Brien P. Riley
  • Kenneth S. Kendler
  • Shane E. McCarthy
  • William R. McCombie
  • Alex Richards
  • Michael J. Owen
  • Michael C. O'Donovan
  • James Walters
  • Peter Donnelly
  • Lesley Bates
  • Ines Barroso
  • Jenefer M. Blackwell
  • Elvira Bramon
  • Matthew A. Brown
  • Juan P. Casas
  • Aiden Corvin
  • Panos Deloukas
  • Audrey Duncanson
  • Janusz Jankowski
  • Hugh S. Markus
  • Christopher G. Mathew
  • Colin N.A. Palmer
  • Robert Plomin
  • Anna Rautanen
  • Stephen J. Sawcer
  • Richard C. Trembath
  • Ananth C. Viswanathan
  • Nicholas W. Wood
  • Chris C.A. Spencer
  • Gavin Band
  • Céline Bellenguez
  • Colin Freeman
  • Garrett Hellenthal
  • Eleni Giannoulatou
  • Lucinda Hopkins
  • Matti Pirinen
  • Richard Pearson
  • Amy Strange
  • Zhan Su
  • Damjan Vukcevic
  • Pers, Tune H
  • Mark Hansen
  • Hansen, Thomas Folkmann
  • Tao Li
  • Line Olsen
  • Christos Pantelis
  • Rasmussen, Henrik Berg
  • Werge, Thomas
  • Wellcome Trust Case Control Consortium 2
  • Schizophrenia Working Group of the Psychiatric Genomics Consortium

Genome-wide association studies (GWASs) are highly effective at identifying common risk variants for schizophrenia. Rare risk variants are also important contributors to schizophrenia etiology but, with the exception of large copy number variants, are difficult to detect with GWAS. Exome and genome sequencing, which have accelerated the study of rare variants, are expensive so alternative methods are needed to aid detection of rare variants. Here we re-analyze an Irish schizophrenia GWAS dataset (n = 3,473) by performing identity-by-descent (IBD) mapping followed by exome sequencing of individuals identified as sharing risk haplotypes to search for rare risk variants in coding regions. We identified 45 rare haplotypes (>1 cM) that were significantly more common in cases than controls. By exome sequencing 105 haplotype carriers, we investigated these haplotypes for functional coding variants that could be tested for association in independent GWAS samples. We identified one rare missense variant in PCNT but did not find statistical support for an association with schizophrenia in a replication analysis. However, IBD mapping can prioritize both individual samples and genomic regions for follow-up analysis but genome rather than exome sequencing may be more effective at detecting risk variants on rare haplotypes.

Original languageEnglish
JournalAmerican Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
Volume180
Issue number3
Pages (from-to)223-231
Number of pages9
ISSN1552-4841
DOIs
Publication statusPublished - 2019

    Research areas

  • GWAS, IBD mapping, rare variants

ID: 260352324